Nieuws & Media
Deze persberichten zijn bedoeld als referentiemateriaal voor investeerders en journalisten en zijn alleen beschikbaar in het Engels. De informatie in ieder persbericht was bijgewerkt ten tijde van de publicatie en KCI accepteert geen verantwoordelijkheid voor het bijwerken van de informatie met latere ontwikkelingen.
Hoofdartikelen
Acelity Acquires SNaP® Disposable Negative Pressure Wound Therapy System to Expand Offering in Portable, Non-Powered NPWT Technology
Acquisition accelerates Acelity’s strategy in the disposable negative pressure wound therapy market
Acelity Increases Focus on Growth, Expansion Opportunities
Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing
Titels
Acelity Expands Wound Care Portfolio with Introduction of Advanced Foam Dressing Line in the U.S.
Seven new products now available from the TIELLE™ Foam Dressing Family complement extensive therapeutic options for chronic and acute wounds
ACELITY L.P. INC. REPORTS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS FOR 2015
Total Revenue for the Fourth Quarter and Full Year of 2015 Grows 3.4% and 4.0%, respectively, on a Constant Currency Basis
Acelity Expands TIELLE™ Advanced Foam Dressing Portfolio in Europe
TIELLE Silicone Border combines proven absorption technology with a soft silicone adhesive; provides clinicians a new option to minimize pain and trauma for patients living with wounds
ACELITY L.P. INC. REPORTS THIRD QUARTER AND FIRST NINE MONTHS FINANCIAL RESULTS FOR 2015
Total Revenue Grew 3.3% on a Constant Currency Basis
Acelity Deepens Commitment to Medical Education with Launch of Centres of Expertise Program in Europe
Acelity Announces Expansion of Prevena™ Therapy Portfolio with Addition of Shorter Peel & Place™ System
Acelity Partners with GHD to Expand Access to Advanced Wound Dressing Portfolio in Germany
Partnership increases Acelity’s Footprint in German Market
Acelity L.P. Inc. Reports Second Quarter and First Half Financial Results for 2015
U.S. Advanced Wound Therapeutics revenue grew 10%
Published Literature Review Demonstrates Promise of V.A.C. VeraFlo™ Therapy in Wound Treatment